These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Place of calcium antagonists in the treatment of hypertension. Kiowski W. Cor Vasa; 1990; 32(2 Suppl 1):2-11. PubMed ID: 2200638 [Abstract] [Full Text] [Related]
3. Mechanisms of action and clinical use of calcium antagonists in hypertension. Kiowski W, Bolli P, Erne P, Müller FB, Hulthén UL, Bühler FR. Circulation; 1989 Dec; 80(6 Suppl):IV136-44. PubMed ID: 2557176 [Abstract] [Full Text] [Related]
6. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade. Bolli P, Erne P, Hulthén UL, Ritz R, Kiowski W, Ji BH, Bühler FR. J Cardiovasc Pharmacol; 1984 Aug; 6 Suppl 7():S996-1001. PubMed ID: 6085391 [Abstract] [Full Text] [Related]
7. Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. Erne P, Bolli P, Bürgisser E, Bühler FR. N Engl J Med; 1984 Apr 26; 310(17):1084-8. PubMed ID: 6143260 [Abstract] [Full Text] [Related]
8. Pharmacological basis for use of calcium antagonists in hypertension. Scriabine A, Kazda S. Magnesium; 1989 Apr 26; 8(5-6):253-65. PubMed ID: 2693846 [Abstract] [Full Text] [Related]
9. Calcium antagonists and their potential for antihypertensive therapy. Bühler FR, Kiowski W. Ann N Y Acad Sci; 1988 Apr 26; 522():584-99. PubMed ID: 3288062 [Abstract] [Full Text] [Related]
10. Recognizing and treating two types of long-term vasoconstriction in hypertension. Laragh JH, Resnick LM. Kidney Int Suppl; 1988 Sep 26; 25():S162-74. PubMed ID: 3054233 [Abstract] [Full Text] [Related]
11. Comparison of calcium-entry blockers and diuretics in the treatment of hypertensive patients. Sowers JR, Mohanty PK. Circulation; 1987 Jun 26; 75(6 Pt 2):V170-3. PubMed ID: 3552313 [Abstract] [Full Text] [Related]
12. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension. Kazda S, Garthoff B, Knorr A. Fed Proc; 1983 Feb 26; 42(2):196-200. PubMed ID: 6822291 [Abstract] [Full Text] [Related]
13. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats. Aoki K, Kawaguchi Y, Sato K, Kondo S, Yamamoto M. J Cardiovasc Pharmacol; 1982 Feb 26; 4 Suppl 3():S298-302. PubMed ID: 6184557 [Abstract] [Full Text] [Related]
14. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis]. Brandt D. Wien Med Wochenschr; 1983 Mar 31; 133(6):131-5. PubMed ID: 6134398 [Abstract] [Full Text] [Related]
15. [Are all antihypertensive drugs renoprotective?]. Wolf S, Risler T. Herz; 2004 May 31; 29(3):248-54. PubMed ID: 15167950 [Abstract] [Full Text] [Related]
16. The role of calcium antagonists in the treatment of hypertension. Klaus D. J Cardiovasc Pharmacol; 1992 May 31; 20 Suppl 6():S5-14. PubMed ID: 1283189 [Abstract] [Full Text] [Related]
17. The hemodynamics of calcium-channel antagonists in hypertension: vascular and myocardial responses. Cody RJ. Circulation; 1987 Jan 31; 75(1 Pt 2):I175-9. PubMed ID: 3791618 [Abstract] [Full Text] [Related]